These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 41794)

  • 1. Reduction of cinerulose in aclacinomycin-A by soluble and microsomal cinerulose reductases.
    Komiyama T; Oki T; Inui T; Takeuchi T; Umezawa H
    Gan; 1979 Aug; 70(4):395-401. PubMed ID: 41794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of anthracycline glycoside by NADPH--cytochrome P-450 reductase.
    Komiyama T; Oki T; Inui T; Takeuchi T; Umezawa H
    Gan; 1979 Aug; 70(4):403-10. PubMed ID: 41795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADH-dependent cinerulose reductase in rat liver microsomes.
    Komiyama T; Oki T; Inui T; Takeuchi T; Umezawa H
    Biochem Biophys Res Commun; 1978 May; 82(1):188-95. PubMed ID: 208552
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzymatic conversion of aclacinomycin A to Y by a specific oxidoreductase in Streptomyces.
    Yoshimoto A; Ogasawara T; Kitamura I; Oki T; Inui T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1979 May; 32(5):472-81. PubMed ID: 528393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
    Mimnaugh EG; Gram TE; Trush MA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
    Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
    J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the stability of aclacinomycin hydrochloride. I. Stability of solution of aclacinomycin hydrochloride (author's transl)].
    Mori S; Shindo N; Miura H; Oki T; Inui T
    Jpn J Antibiot; 1980 Apr; 33(4):466-71. PubMed ID: 7411850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-sensitivity relationship of anthracycline antibiotics to C7-reduction by redox enzymes.
    Yoshimoto A; Tobe H; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):287-95. PubMed ID: 1908911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for aclacinomycin A.
    Matsuzawa Y; Kiyosaki T; Oki T; Takeuchi T; Umezawa H
    Gan; 1982 Apr; 73(2):229-33. PubMed ID: 6956531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
    Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative anthracycline metabolism in rats: loss of marcellomycin fluorescence.
    Dodion P; Tamburini JM; Fox BM; Riggs CE; Bachur NR
    Cancer Res; 1986 Jun; 46(6):2714-9. PubMed ID: 3084076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment.
    Kukiełka E; Dicker E; Cederbaum AI
    Arch Biochem Biophys; 1994 Mar; 309(2):377-86. PubMed ID: 8135551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active site.
    Alexeev I; Sultana A; Mäntsälä P; Niemi J; Schneider G
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6170-5. PubMed ID: 17395717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
    Doroshow JH
    Cancer Res; 1983 Feb; 43(2):460-72. PubMed ID: 6293697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
    Marohnic CC; Bewley MC; Barber MJ
    Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.